Kane Biotech Inc Stock Toronto S.E.
Equities
KNE
CA4838092084
Biotechnology & Medical Research
Sales 2022 | 2.67M 1.95M | Sales 2023 | 149K 109K | Capitalization | 10.55M 7.71M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.19M | Net income 2023 | -5M -3.66M | EV / Sales 2022 | 6.37 x |
Net Debt 2022 | 5.76M 4.21M | Net Debt 2023 | 8.51M 6.22M | EV / Sales 2023 | 128 x |
P/E ratio 2022 |
-2.79
x | P/E ratio 2023 |
-2.02
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.07% |
Latest transcript on Kane Biotech Inc
Managers | Title | Age | Since |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 16-06-01 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 17-09-04 |
Compliance Officer | - | 19-08-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 10-09-14 |
Chairman | 59 | Feb. 19 | |
Georges Morin
BRD | Director/Board Member | - | 20-05-19 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |